Tempus Wealth Planning’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,629
| Closed | -$230K | – | 256 |
|
|
2024
Q3 | $230K | Hold |
5,629
| – | – | 0.08% | 201 |
|
|
2024
Q2 | $217K | Hold |
5,629
| – | – | 0.09% | 187 |
|
|
2024
Q1 | $241K | Hold |
5,629
| – | – | 0.11% | 174 |
|
|
2023
Q4 | $209K | Sell |
5,629
-48
| -0.8% | -$1.78K | 0.09% | 184 |
|
|
2023
Q3 | $206K | Sell |
5,677
-1,280
| -18% | -$46.4K | 0.1% | 156 |
|
|
2023
Q2 | $248K | Sell |
6,957
-12,288
| -64% | -$438K | 0.11% | 157 |
|
|
2023
Q1 | $685K | Sell |
19,245
-86
| -0.4% | -$3.06K | 0.33% | 77 |
|
|
2022
Q4 | $679K | Buy |
+19,331
| New | +$679K | 0.41% | 75 |
|
|
2022
Q3 | – | Sell |
-14,062
| Closed | -$765K | – | 181 |
|
|
2022
Q2 | $765K | Sell |
14,062
-912
| -6% | -$49.6K | 0.63% | 45 |
|
|
2022
Q1 | $815K | Sell |
14,974
-2,545
| -15% | -$139K | 0.58% | 48 |
|
|
2021
Q4 | $966K | Buy |
17,519
+11,653
| +199% | +$643K | 0.52% | 57 |
|
|
2021
Q3 | $280K | Buy |
5,866
+160
| +3% | +$7.64K | 0.16% | 130 |
|
|
2021
Q2 | $284K | Buy |
5,706
+140
| +3% | +$6.97K | 0.19% | 124 |
|
|
2021
Q1 | $248K | Buy |
5,566
+480
| +9% | +$21.4K | 0.26% | 86 |
|
|
2020
Q4 | $234K | Sell |
5,086
-2,400
| -32% | -$110K | 0.3% | 64 |
|
|
2020
Q3 | $352K | Sell |
7,486
-160
| -2% | -$7.52K | 0.51% | 45 |
|
|
2020
Q2 | $390K | Hold |
7,646
| – | – | 0.58% | 33 |
|
|
2020
Q1 | $362K | Sell |
7,646
-260
| -3% | -$12.3K | 0.59% | 30 |
|
|
2019
Q4 | $464K | Buy |
+7,906
| New | +$464K | 0.41% | 37 |
|